Match!
Marco Oderda
University of Turin
UrologySurgeryProstate cancerBladder cancerMedicine
158Publications
13H-index
689Citations
What is this?
Publications 166
Newest
#1Giancarlo MarraH-Index: 44
#2Junlong ZhuangH-Index: 8
Last. Riccardo FalettiH-Index: 11
view all 18 authors...
Source
#1Giancarlo MarraH-Index: 44
#2Junlong ZhuangH-Index: 8
Last. Riccardo FalettiH-Index: 11
view all 16 authors...
Source
#1Marco OderdaH-Index: 13
Last. Paolo GonteroH-Index: 32
view all 10 authors...
Source
#2M. BaraleH-Index: 1
Last. Paolo GonteroH-Index: 32
view all 6 authors...
Source
#1Giancarlo MarraH-Index: 44
#2Paolo GonteroH-Index: 32
Last. Sanchia S. GoonewardeneH-Index: 3
view all 36 authors...
Source
#1Marco Falcone (UNITO: University of Turin)H-Index: 9
#2Marco Oderda (UNITO: University of Turin)H-Index: 13
Last. Paolo Gontero (UNITO: University of Turin)H-Index: 32
view all 3 authors...
Source
#1Marco Oderda (UNITO: University of Turin)H-Index: 13
#2Morgan Rouprêt (University of Paris)H-Index: 36
Last. Paolo Gontero (UNITO: University of Turin)H-Index: 32
view all 9 authors...
Source
#1D. Deandreis (UNITO: University of Turin)H-Index: 12
#2Alessia GuarneriH-Index: 10
Last. Andrea Zitella (UNITO: University of Turin)H-Index: 12
view all 15 authors...
OBJECTIVES: The primary objective is to assess the efficacy of (68)Ga-PSMA-11-PET/CT to detect recurrent location(s) in hormone-sensitive prostate cancer (PCa). Secondary objectives are (1) to evaluate changes in clinical management; (2) to determine which covariates independently predict positive scan; (3) to assess (68)Ga-PSMA-11-PET/CT performance in different settings of PSA relapse. MATERIALS AND METHODS: Inclusion criteria include (1) histologically diagnosed PCa; (2) previous radical ther...
Source
#1Marco Falcone (UNITO: University of Turin)H-Index: 9
#2Marco Oderda (UNITO: University of Turin)H-Index: 13
Last. Paolo Gontero (UNITO: University of Turin)H-Index: 32
view all 3 authors...
Source
#1Giancarlo Marra (UNITO: University of Turin)H-Index: 6
#2A. Marquis (UNITO: University of Turin)
Last. Andrea Zitella (UNITO: University of Turin)H-Index: 12
view all 12 authors...
Abstract Objective To evaluate the feasibility of ‘’in-office’’ TPFBx under LA. Materials and Methods We prospectively screened for eligibility data of 724 consecutive men undergoing either TPFBx (target and systematic cores) or TPSBx (systematic cores only) from September 2016 to June 2018 due to suspicion of PCa, according to pre-defined exclusion criteria. Results We included 459 men (TPFBx n=279 including n=338 mpMRI lesions, Pi-RADS 4 in 63.6%; TPSBx n=180). Median procedural time and maxim...
Source
12345678910